Guy P Nohra's Net Worth
$205 Million
Who is Guy P Nohra?
Guy P Nohra has an estimated net worth of $205 Million. This is based on reported shares across multiple companies, which include IMMUNE DESIGN CORP., COTHERIX INC, ANESIVA, INC., ZS Pharma, Inc., Allakos Inc., SUTRO BIOPHARMA INC, Esperion Therapeutics, Inc., TREVENA INC, APPLIED GENETIC TECHNOLOGIES CORP, aTYR PHARMA INC, Neothetics, Inc., RENOVIS INC, ATS MEDICAL INC, CUTERA INC, DYNAVAX TECHNOLOGIES CORP, NeurogesX Inc, RIGEL PHARMACEUTICALS INC, ACELRX PHARMACEUTICALS INC, XCYTE THERAPIES INC, ICAGEN INC, FLAMEL TECHNOLOGIES SA, INTARCIA THERAPEUTICS, INC, TorreyPines Therapeutics, Inc., CRUCELL NV, OCCAM NETWORKS INC/DE, AERIE PHARMACEUTICALS INC, ELLIE MAE INC, Bioventus Inc., and Carbylan Therapeutics, Inc..
SEC CIK
Guy P Nohra's CIK is 0001198330
Past Insider Trading and Trends
2014 was Guy P Nohra's most active year for acquiring shares with 29 total transactions. Guy P Nohra's most active month to acquire stocks was the month of January. 2004 was Guy P Nohra's most active year for disposing of shares, totalling 84 transactions. Guy P Nohra's most active month to dispose stocks was the month of March. 2007 saw Guy P Nohra paying a total of $16,415,000.00 for 13,498,673 shares, this is the most they've acquired in one year. In 2003 Guy P Nohra cashed out on 3,325,000 shares for a total of $63,177,849.99, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
IMMUNE DESIGN CORP. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.48M |
$12.00 |
—
| 2.48M |
Jul 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COTHERIX INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -2.95M |
$13.50 | -$39,876,111.00 |
0
|
Jan 9
| |||
Form 4
| -15.54% | -357.56K |
—
|
—
| 1.94M |
Nov 7
| |||
Form 4
| -14.96% | -166.94K |
$13.00 | -$2,170,181.00 | 948.95K |
Oct 14
| |||
Form 4
| -18.14% | -247.31K |
$13.00 | -$3,215,082.00 | 1.12M |
Oct 12
| |||
Form 4
| +169.64% | 3.64M |
$6.00 | $2,499,996.00 | 5.79M |
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ANESIVA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.04% | -404.65K |
$0.09 | -$37,146.87 | 6.29M |
Jan 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
|
∞
| 2.1M |
—
|
—
| 2.1M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ZS Pharma, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.00K |
$90.00 | -$90,000.00 |
0
|
Dec 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -6.22% | -175.43K |
$57.86 | -$10,149,794.76 | 2.65M |
Jun 5 - Jun 8
| |||
Form 4
| -3.80% | -111.60K |
$57.30 | -$6,394,775.58 | 2.82M |
Jun 3 - Jun 4
| |||
Form 4
| -9.18% | -296.42K |
$58.00 | -$17,192,294.53 | 2.93M |
May 29 - Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 22
| |||
Form 4
|
∞
| 3.23M |
$18.00 |
—
| 3.23M |
Jun 23
| |||
Form 4
|
∞
| 3.23M |
$18.00 |
—
| 3.23M |
Jun 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Allakos Inc. (ALLK) Snapshot price: $1.27
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -25.77K |
$111.64 | -$2,876,741.72 |
0
|
Mar 4
| |||
Form 4
| -100.00% | -7.69K |
$75.62 | -$581,693.10 |
0
|
Jun 17
| |||
Form 4
| -8.32% | -958.55K |
—
|
—
| 10.56M |
Jan 22
| |||
Form 4
|
∞
| 11.52M |
$18.00 |
—
| 11.52M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |